APA

Khan O. A., Tselis A. C., Kamholz J. A., Garbern J. Y., Lewis R. A. & Lisak R. P. (20010802). A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis. : European journal of neurology.

Chicago

Khan O A, Tselis A C, Kamholz J A, Garbern J Y, Lewis R A and Lisak R P. 20010802. A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis. : European journal of neurology.

Harvard

Khan O. A., Tselis A. C., Kamholz J. A., Garbern J. Y., Lewis R. A. and Lisak R. P. (20010802). A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis. : European journal of neurology.

MLA

Khan O A, Tselis A C, Kamholz J A, Garbern J Y, Lewis R A and Lisak R P. A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis. : European journal of neurology. 20010802.